What's Going On With Hologic Shares Today?

Hologic, Inc. HOLX shares are trading higher today after the company reported preliminary first-quarter revenue results.

What happened: Hologic on Sunday announced that the company expects to report revenues of approximately $1.074 billion for the first quarter of 2023. These expected results are higher than the previous revenue guidance range of $940 to $990 million.

Favorable revenue estimates are driven by double-digit organic currency growth numbers, including:

• 15.8% in Diagnostics ex-COVID
• 24.5% in Molecular Diagnostics ex-COVID
• 14.7% in Surgical

Steve MacMillan, Hologic’s Chairman, CEO, and President states, “Our preliminary revenue results once again showcase the strength of our franchises, with more growth drivers in each, powering Hologic in fiscal 2023.”

Hologic manufactures proprietary products for the healthcare needs of women, including diagnostics, breast health, surgical, and skeletal health.

According to data from Benzinga Pro, Hologic Inc. shares were up 3.91% at $80.87 at the time of publication. It has a 52-week high of $80.49, and a 52-week low of $59.78.